700 - Motif Bio #MTFB Charlie Long on Zenith Energy #ZEN Doc on #CTAG #PREM #URU #TLOU

Feb 02, 2017, 12:09 PM

Graham Lumsden, CEO, of Motif Bio #MTFB talks about the completion of the REVIVE-1 study, which in the Phase 3 clinical trial investigating the safety and efficacy of iclaprim. (Interview starts at 1 minutes 29 seconds)

Charlie Long, resources analyst at Beaufort Securities talks about Zenith Energy #ZEN (Interview starts at 16 minutes 15 seconds)

Small cap commentator Doc Holiday talks about: Tlou Energy #TLOU Cloudtag #CTAG Premier African Minerals #PREM URU Metals #URU (Interview starts at 23 minutes 05 seconds)

Chris Bailey founder of Financial Orbit covers: Royal Dutch Shell #RDSB Astrazeneca #AZN BT #BT.A Vodafone #VOD (Interview starts at 40 minutes 13 seconds)

Plus The Top 5 Most Followed Companies on Vox Markets in the Last 24 Hours and The Top 5 Most Liked RNS's on the Vox Markets website this morning. (Feature starts at 48 minutes 39 seconds)

For more information on any of the companies above, please visit: http://www.voxmarkets.co.uk/blog